These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32783978)

  • 1. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs.
    Bazzo GC; Pezzini BR; Stulzer HK
    Int J Pharm; 2020 Oct; 588():119741. PubMed ID: 32783978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Technical Approach of Solubility Enhancement of Poorly Soluble Drugs: Liquisolid Technique.
    Chaudhary N; Tripathi D; Rai AK
    Curr Drug Deliv; 2020; 17(8):638-650. PubMed ID: 32416691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.
    Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F
    Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and evaluation of celecoxib eutectic mixtures with adipic acid/saccharin for improvement of wettability and dissolution rate.
    Hyun SM; Lee BJ; Abuzar SM; Lee S; Joo Y; Hong SH; Kang H; Kwon KA; Velaga S; Hwang SJ
    Int J Pharm; 2019 Jan; 554():61-71. PubMed ID: 30347274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs.
    Bertoni S; Albertini B; Passerini N
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31557815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
    Kumar S; Gupta SK
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure.
    Law D; Wang W; Schmitt EA; Qiu Y; Krill SL; Fort JJ
    J Pharm Sci; 2003 Mar; 92(3):505-15. PubMed ID: 12587112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving drug solubility for oral delivery using solid dispersions.
    Leuner C; Dressman J
    Eur J Pharm Biopharm; 2000 Jul; 50(1):47-60. PubMed ID: 10840192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of ezetimibe eutectic with improved biopharmaceutical and mechanical properties to design an optimized oral solid dosage formulation.
    Roy P; Kumari N; Pandey N; Gour A; Raj A; Srividya B; Nandi U; Ghosh A
    Pharm Dev Technol; 2022 Dec; 27(10):989-998. PubMed ID: 36322702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application research of hot-melt extrusion in preparation of solid dispersion].
    Chen MW; Chen WR; Chen TK; Chen RE; Wang YT
    Yao Xue Xue Bao; 2012 Feb; 47(2):163-7. PubMed ID: 22512025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.
    Tran P; Park JS
    Int J Pharm; 2021 Dec; 610():121247. PubMed ID: 34740762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of domperidone solid dispersions.
    Essa EA; Balata GF
    Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.